Icosabutate

DB12990InvestigationalSmall molecule

Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study).

Chemical structure of Icosabutate
Mechanism
Curator reviewed
Formula / weight
C24H38O3 · 374.565 g/mol (avg)

Resolves to

Compound
UNII562599X5JLCAS1253909-57-7ChEMBLCHEMBL3707220PubChem78210211
Structure
InChIKeyVOGXDRFFBBLZBT-AAQCHOMXSA-NSMILESCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCOC(CC)C(O)=O
Targets
O14842FFAR1Q5NUL3FFAR4

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Icosabutate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In